NYSE$THC
Tenet Healthcare Corp · Q2 2021 earnings
Q2 2021 earnings · · Investor relations
Briefing
Tenet Healthcare's Q2 2021 results reflected long-term strategy and transformation progress.
Tenet Healthcare reported a strong second quarter in 2021, with net income from continuing operations available to common shareholders of $120 million, or $1.11 per diluted share, compared to $88 million, or $0.83 per diluted share, in Q2 2020. Adjusted EBITDA was $834 million, and adjusted diluted earnings per share from continuing operations were $1.59. The company raised its full-year 2021 financial guidance, citing continued growth, operational improvements, and grant income.
- Net income from continuing operations available to common shareholders in Q2 2021 was $120 million, compared to $88 million in Q2 2020.
- Consolidated Adjusted EBITDA in Q2 2021 was $834 million versus $732 million in Q2 2020.
- Diluted earnings per share from continuing operations available to common shareholders in Q2 2021 was $1.11 compared to $0.83 in Q2 2020; Adjusted diluted earnings per share from continuing operations of $1.59 in Q2 2021 compared to $1.26 in Q2 2020.
- The FY 2021 Outlook was increased due to continued growth and operational improvements as well as grant income.
Headline financials
Revenue & EPS history
Tenet Healthcare · Revenue · Quarterly
$4.95B
Revenue by segment
Tenet Healthcare · $4.76B total across 2 segments · Q2 2021
- Hospital Operations$4.1B+32.6%86.0%
- Ambulatory Care$664M+80.4%14.0%
Forward guidance
Tenet Healthcare raised its full-year 2021 outlook, expecting net operating revenues between $19.250 billion and $19.650 billion, Adjusted EBITDA between $3.150 billion and $3.250 billion, and Adjusted diluted earnings per share between $5.23 and $5.73.
Tailwinds
- Net operating revenues are expected to be between $19,250 million and $19,650 million.
- Adjusted EBITDA is projected to be between $3,150 million and $3,250 million.
- Diluted income per common share from continuing operations is anticipated to be between $6.25 and $7.17.
- Adjusted net income from continuing operations is expected to be between $570 million and $625 million.
- Adjusted diluted earnings per share from continuing operations are projected to be between $5.23 and $5.73.
Headwinds
- Interest expense is expected to be between $935 million and $945 million.
- Depreciation and amortization are projected to be between $850 million and $870 million.
- Capital expenditures are estimated to be between $700 million and $750 million.
- NCI cash distributions are expected to be between $460 million and $480 million.
- Effective tax rate is projected to be ~17%.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2021
-1.0%
Avg return
Earnings day
+1.0%
Avg return
5 days after
+3.0%
Avg return
30 days after
49%
33 / 68 earnings
Positive
+13.3%
Q3 2024
Best reaction
-31.1%
Q3 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.7% | +3.8% | -2.8% | |
| Q4 2025 | -0.7% | +6.4% | +29.3% | |
| Q3 2025 | -5.3% | -4.5% | +0.6% | |
| Q2 2025 | +0.3% | +3.6% | +12.2% | |
| Q1 2025 | +0.2% | -9.6% | +7.4% | |
| Q4 2024 | -9.1% | -4.0% | -11.6% | |
| Q3 2024 | +13.3% | +11.9% | +1.8% | |
| Q2 2024 | +8.0% | +10.2% | +18.6% | |
| Q1 2024 | -0.7% | -2.8% | +6.8% | |
| Q4 2023 | -0.0% | +6.9% | +14.0% | |
| Q3 2023 | +1.1% | +3.4% | +26.8% | |
| Q2 2023 | +3.3% | +0.2% | +5.4% | |
| Q1 2023 | +1.5% | +5.6% | +27.3% | |
| Q4 2022 | -3.2% | +13.8% | -3.3% | |
| Q3 2022 | -31.1% | -24.0% | -17.2% | |
| Q2 2022 | +7.8% | +7.9% | +7.9% | |
| Q1 2022 | -0.3% | -8.0% | -16.6% | |
| Q4 2021 | -5.3% | +12.1% | +23.0% | |
| Q3 2021 | +9.3% | +6.7% | +20.2% | |
| Q2 2021 | -0.7% | +1.6% | +3.0% | |
| Q1 2021 | -3.7% | -4.5% | +11.5% | |
| Q4 2020 | -5.1% | -4.7% | +6.3% | |
| Q3 2020 | +0.9% | +3.4% | +12.9% | |
| Q2 2020 | +0.6% | +10.1% | +10.6% | |
| Q1 2020 | -8.6% | +19.3% | +34.4% | |
| Q4 2019 | -14.5% | -23.2% | -47.4% | |
| Q3 2019 | +8.6% | +14.8% | +30.4% | |
| Q2 2019 | -3.8% | -5.0% | -7.9% | |
| Q1 2019 | +3.2% | +8.1% | -24.1% | |
| Q4 2018 | +11.5% | +21.6% | +16.5% | |
| Q3 2018 | -9.3% | -3.2% | -8.7% | |
| Q2 2018 | -15.6% | -15.9% | -17.4% | |
| Q1 2018 | -4.4% | +0.7% | -1.3% | |
| Q4 2017 | +7.7% | +13.7% | +23.6% | |
| Q3 2017 | +7.7% | +9.2% | +4.6% | |
| Q2 2017 | -14.8% | -16.2% | +2.3% | |
| Q1 2017 | -4.1% | -3.6% | -13.8% | |
| Q4 2016 | -12.2% | -4.5% | -18.5% | |
| Q3 2016 | -5.6% | -12.3% | -24.8% | |
| Q2 2016 | -9.9% | -10.2% | -21.9% | |
| Q1 2016 | -0.1% | — | — | |
| Q4 2015 | +5.4% | — | — | |
| Q3 2015 | +9.2% | — | — | |
| Q2 2015 | +2.1% | — | — | |
| Q1 2015 | -3.2% | — | — | |
| Q4 2014 | +1.0% | — | — | |
| Q3 2014 | -5.3% | — | — | |
| Q2 2014 | +4.8% | — | — | |
| Q1 2014 | +1.7% | — | — | |
| Q4 2013 | -6.3% | — | — | |
| Q3 2013 | -6.8% | — | — | |
| Q2 2013 | -7.0% | — | — | |
| Q1 2013 | +0.9% | — | — | |
| Q4 2012 | +3.5% | — | — | |
| Q3 2012 | +5.4% | — | — | |
| Q2 2012 | +11.8% | — | — | |
| Q1 2012 | +1.1% | — | — | |
| Q4 2011 | +0.0% | — | — | |
| Q3 2011 | +4.9% | — | — | |
| Q2 2011 | -4.6% | — | — | |
| Q1 2010 | -6.3% | — | — | |
| Q1 2011 | +1.6% | — | — | |
| Q4 2008 | +3.0% | — | — | |
| Q3 2009 | +0.0% | — | — | |
| Q3 2010 | +0.0% | — | — | |
| Q2 2009 | +0.7% | — | — | |
| Q2 2010 | +0.7% | — | — | |
| Q4 2009 | +0.7% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro